Scott Fisher
Scott Fisher
Research Scientist, University of Western Australia School of Biomedical Sciences
Verified email at - Homepage
Cited by
Cited by
Immunotherapy for lung cancer
A Steven, SA Fisher, BW Robinson
Respirology 21 (5), 821-833, 2016
Tumor progression despite efficient tumor antigen cross-presentation and effective “arming” of tumor antigen-specific CTL
DJ Nelson, S Mukherjee, C Bundell, S Fisher, D Van Hagen, B Robinson
The Journal of Immunology 166 (9), 5557-5566, 2001
Growth in the Presence of Salicylate Increases Fluoroquinolone Resistance in Staphylococcus aureus
JE Gustafson, PV Candelaria, SA Fisher, JP Goodridge, TM Lichocik, ...
Antimicrobial Agents and Chemotherapy 43 (4), 990-992, 1999
The “Trojan Horse” approach to tumor immunotherapy: targeting the tumor microenvironment
D Nelson, S Fisher, B Robinson
Journal of immunology research 2014 (1), 789069, 2014
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
CM Tilsed, SA Fisher, AK Nowak, RA Lake, WJ Lesterhuis
Frontiers in oncology 12, 960317, 2022
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint Therapy
N Principe, J Kidman, S Goh, CM Tilsed, SA Fisher, VS Fear, CA Forbes, ...
Frontiers in Immunology 11, 584423, 2020
Combination immune checkpoint blockade as an effective therapy for mesothelioma
VS Fear, C Tilsed, J Chee, CA Forbes, T Casey, JN Solin, SM Lansley, ...
Oncoimmunology 7 (10), e1494111, 2018
Transient Treg depletion enhances therapeutic anti-cancer vaccination
SA Fisher, WJ Aston, J Chee, A Khong, AL Cleaver, JN Solin, S Ma, ...
Immunity, Inflammation and Disease, 1-13, 2016
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen
J Creaney, S Ma, SA Sneddon, MR Tourigny, IM Dick, JS Leon, A Khong, ...
Oncoimmunology 4 (7), e1011492, 2015
The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40
A Khong, AL Cleaver, M Fahmi Alatas, BC Wylie, T Connor, SA Fisher, ...
BMC cancer 14, 1-9, 2014
Chemotherapy Enhances Cross-Presentation of Nuclear Tumor Antigens
CC Anyaegbu, RA Lake, K Heel, BW Robinson, SA Fisher
PLoS ONE 9 (9), e107894, 2014
The search for an interesting partner to combine with PD-L1 blockade in mesothelioma: focus on TIM-3 and LAG-3
E Marcq, JRM Van Audenaerde, J De Waele, C Merlin, P Pauwels, ...
Cancers 13 (2), 282, 2021
Tumour draining lymph node‑generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used
VS Fear, CA Forbes, N S.A, F S.A, J Chee, J Waithman, S Ma, RA Lake, ...
Cancer Immunology, Immunotherapy, 2021
Bibliometric analysis of gaps in research on asbestos-related diseases: declining emphasis on public health over 26 years
RT Lin, MJ Soeberg, LC Chien, S Fisher, J Takala, R Lemen, T Driscoll, ...
BMJ Open 8 (7), e022806, 2018
Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis—implications for tumor …
BWS Robinson, BM Scott, RA Lake, PA Stumbles, DJ Nelson, S Fisher, ...
Clinical cancer research 7 (3), 811s-817s, 2001
Interferon-γ response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis
MW Watson, A Jaksic, P Price, W Cheng, M McInerney, MA French, ...
The Journal of infectious diseases 188 (10), 1533-1536, 2003
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival
SA Fisher, A Cleaver, DD Lakhiani, A Khong, T Connor, B Wylie, ...
Journal of Translational Medicine 12, 1-9, 2014
Combining chemotherapy and checkpoint blockade in thoracic cancer: how to proceed?
WJ Aston, SA Fisher, A Khong, C Mok, AK Nowak, RA Lake, ...
Lung Cancer Management 3 (6), 443-457, 2014
CD4+ T cells drive an inflammatory, TNF-α/IFN-rich tumor microenvironment responsive to chemotherapy
CM Tilsed, N Principe, J Kidman, WL Chin, MLO Morales, RM Zemek, ...
Cell Reports 41 (13), 2022
Comprehensive testing of chemotherapy and immune checkpoint blockade in preclinical cancer models identifies additive combinations
N Principe, WJ Aston, DE Hope, CM Tilsed, SA Fisher, L Boon, IM Dick, ...
Frontiers in immunology 13, 872295, 2022
The system can't perform the operation now. Try again later.
Articles 1–20